Amazon’s vision for healthcare future comes into focus

Amy Baxter | | Health Exec | Policy & Regulations

Amazon’s foray into the healthcare space has taken many forms so far, but experts are still piecing together the whole story of what the e-commerce giant is planning, CNBC reported.

Over the past year, Amazon has announced a joint venture with Berkshire Hathaway and JPMorgan Chase, acquired online pharmacy PillPack for approximately $1 billion, and made a slew of hires to head its healthcare efforts, among other actions. However, these steps likely don’t tell the whole story.

Amazon’s voice technology system Alexa is poised to step into the healthcare arena even more in the future, experts predicted. Recently, the company has also explored at-home healthcare testing, according to CNBC.

Across all its platforms and partnerships, Amazon appears to be firing on all cylinders to tap into the healthcare market.

See the full story below:

Amazon's vision for the future of health care is becoming clear

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Looming fear of more IV shortages as Hurricane Rafael gains strength
Walgreens settles class-action fraud lawsuit for $100M
Boston Medical Center installs solar panels to pay patients’ electric bills
4 points crucial to the nimble regulation of GenAI
FDA recalls infant incubators due to risk of door falling off
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

Around the web

AI in Healthcare
4 points crucial to the nimble regulation of GenAI

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Design by Adaptive Theme
Trimed Popup
Trimed Popup